Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Resmed (RSMDF) Raw Materials (2016 - 2025)

Historic Raw Materials for Resmed (RSMDF) over the last 16 years, with Q4 2025 value amounting to $374.7 million.

  • Resmed's Raw Materials rose 271.89% to $374.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $374.7 million, marking a year-over-year increase of 271.89%. This contributed to the annual value of $367.3 million for FY2025, which is 329.44% up from last year.
  • Latest data reveals that Resmed reported Raw Materials of $374.7 million as of Q4 2025, which was up 271.89% from $363.4 million recorded in Q3 2025.
  • Over the past 5 years, Resmed's Raw Materials peaked at $468.8 million during Q1 2023, and registered a low of $145.4 million during Q1 2021.
  • For the 5-year period, Resmed's Raw Materials averaged around $358.7 million, with its median value being $366.0 million (2024).
  • As far as peak fluctuations go, Resmed's Raw Materials surged by 13399.73% in 2022, and later plummeted by 2255.5% in 2024.
  • Resmed's Raw Materials (Quarter) stood at $322.6 million in 2021, then surged by 43.66% to $463.4 million in 2022, then rose by 0.82% to $467.2 million in 2023, then fell by 21.92% to $364.8 million in 2024, then rose by 2.72% to $374.7 million in 2025.
  • Its last three reported values are $374.7 million in Q4 2025, $363.4 million for Q3 2025, and $367.3 million during Q2 2025.